Professional background

Dimitri Kullmann is a consultant neurologist at the National Hospital for Neurology and Neurosurgery, and professor of neurology at the UCL Queen Square Institute of Neurology.

He trained in Oxford and London, and is a Fellow of the Academy of Medical Sciences and of the Royal Society. He specialises in neurocritical care and myasthenia gravis.

His research interests centre on mechanisms underlying normal and abnormal circuit function in the brain, inherited and acquired disorders of ion channels (channelopathies) and gene therapy for epilepsy.

Research interests

  • Neurocritical care 
  • Myasthenia gravis 
  • Neurological channelopathies 
  • Epilepsy 
  • General neurology

Publications

Crisp SJ, Dixon CL, Jacobson L, Chabrol E, Irani SR, Leite MI, Leschziner G, Slaght SJ, Vincent A, Kullmann DM. Glycine receptor autoantibodies disrupt inhibitory neurotransmission. Brain. 2019 Nov 1;142(11):3398-3410. doi: 10.1093/brain/awz297.

Salpietro V et al. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.Nat Commun. 2019 Jul 12;10(1):3094. doi: 10.1038/s41467-019-10910-w.

Lieb A, Qiu Y, Dixon CL, Heller JP, Walker MC, Schorge S, Kullmann DM. Biochemical autoregulatory gene therapy for focal epilepsy. Nat Med. 2018 Sep;24(9):1324-1329. doi: 10.1038/s41591-018-0103-x.

Crisp SJ, Kullmann DM, Vincent A. Autoimmune synaptopathies. Nat Rev Neurosci. 2016 Feb;17(2):103-17. doi: 10.1038/nrn.2015.27.

Kullmann DM. Neurological channelopathies. Annu Rev Neurosci. 2010;33:151-72. doi: 10.1146/annurev-neuro-060909-153122.